Adam M Burgoyne Selected Research

Imatinib Mesylate (Gleevec)

1/2021	Cancer-associated fibroblast secretion of PDGFC promotes gastrointestinal stromal tumor growth and metastasis.
9/2019	Frequent rectal gastrointestinal stromal tumor recurrences in the imatinib era: Retrospective analysis of an International Patient Registry.
1/2018	A Novel PRKAR1B-BRAF Fusion in Gastrointestinal Stromal Tumor Guides Adjuvant Treatment Decision-Making During Pregnancy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Adam M Burgoyne Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 12/2009
5	Hepatocellular Carcinoma (Hepatoma) 01/2024 - 11/2016
4	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022 - 01/2019
2	Glioblastoma (Glioblastoma Multiforme) 04/2010 - 09/2009
2	Astrocytoma (Pilocytic Astrocytoma) 04/2010 - 12/2009
1	Adenocarcinoma 01/2024
1	Stomach Neoplasms (Stomach Cancer) 01/2024
1	Inflammation (Inflammations) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2022
1	Necrosis 12/2021
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2021
1	Carcinogenesis 01/2019
1	Glioma (Gliomas) 12/2009

Drug/Important Bio-Agent (IBA)

3	Imatinib Mesylate (Gleevec)FDA Link 01/2021 - 01/2018
3	Class 2 Receptor-Like Protein Tyrosine PhosphatasesIBA 04/2010 - 09/2009
2	atezolizumabIBA 01/2024 - 01/2022
2	Immune Checkpoint InhibitorsIBA 11/2022 - 12/2021
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2022 - 01/2019
2	Sorafenib (BAY 43-9006)FDA Link 01/2022 - 11/2016
2	Protein Tyrosine PhosphatasesIBA 04/2010 - 09/2009
2	Peptides (Polypeptides)IBA 04/2010 - 09/2009
1	cabozantinibIBA 01/2024
1	Biomarkers (Surrogate Marker)IBA 11/2022
1	Bevacizumab (Avastin)FDA Link 01/2022
1	Temozolomide (Temodar)FDA LinkGeneric 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	O-methyl-serine dodecylamide hydrochlorideIBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	NivolumabIBA 12/2021
1	platelet-derived growth factor C (PDGF-C)IBA 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2020
1	Succinic Acid (Succinate)IBA 01/2019
1	SF 1126IBA 11/2016
1	sperm releasing substanceIBA 09/2015
1	Proteins (Proteins, Gene)FDA Link 12/2009
1	Small Interfering RNA (siRNA)IBA 09/2009

Therapy/Procedure

5	Therapeutics 01/2022 - 12/2016
1	Transplantation 12/2021
1	Drug Therapy (Chemotherapy) 01/2021